Federal award (DEFINITIVE CONTRACT, fiscal year 2021)
Recipient: THE GENEVA FOUNDATION
Awarding agency: Department of Defense / Department of the Army
Funding agency: Department of Defense / Department of the Army
Period of performance: 2020-06-11 to 2023-06-15
Current total value of award: $263487
Description: RESEARCH CONTRACT TITLED: "CRISPR/CAS9 CELLULAR ENGINEERING FOR THE CREATION OF COAGULATION FACTOR-BASED RESUSCITATION FLUID TO COMBAT HEMORRHAGE AND COAGULOPATHY", NO COST EXTENSION TO PERIOD OF PERFORMANCE.